当前位置: X-MOL 学术J. Clinical Psychopharmacol. › 论文详情
Our official English website, www.x-mol.net, welcomes your feedback! (Note: you will need to create a separate account there.)
Quetiapine in the Anxiety Dimension of Mood Disorders: A Systematic Review of the Literature to Support Clinical Practice.
Journal of Clinical Psychopharmacology ( IF 2.9 ) Pub Date : 2021-06-19 , DOI: 10.1097/jcp.0000000000001420
Calogero Crapanzano 1 , Stefano Damiani 2 , Cecilia Guiot 2
Affiliation  

Bipolar disorder and major depressive disorder are heterogeneous conditions characterized by marked variations in mood. High levels of anxiety are often present in these conditions and are associated with increased suicidal risk, increased disease duration, and treatment resistance. Mood stabilizers or antipsychotics are recommended for the treatment of bipolar disorder in comorbidity with anxiety disorders. This study examines current knowledge to evaluate the efficacy of quetiapine in the treatment of anxiety in mood disorders.

中文翻译:

喹硫平在情绪障碍的焦虑方面:支持临床实践的文献系统评价。

双相情感障碍和重度抑郁症是异质性疾病,其特征是情绪显着变化。在这些情况下通常存在高度焦虑,并且与自杀风险增加、疾病持续时间增加和治疗抵抗有关。推荐使用情绪稳定剂或抗精神病药来治疗双相情感障碍合并焦虑症。本研究检验了目前评估喹硫平治疗情绪障碍焦虑症疗效的知识。
更新日期:2021-06-26
down
wechat
bug